Arrhythmogenic right ventricular cardiomyopathy (ARVC) affects one in 5,000 people worldwide and has been a perennial puzzle for clinicians as to its cause and treatment. Now a cardiologist with the research team that has won Canada's prestigious Governor General's Innovation Award for identifying the gene responsible for the condition is looking to California for assistance in repairing it.